Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 112

Results For "2022"

1413 News Found

Seventh international meet on Pharma and MedTech from April 25-27 in New Delhi
News | March 31, 2022

Seventh international meet on Pharma and MedTech from April 25-27 in New Delhi

The event will have a mix of policymakers, national and international leaders from the pharma industry, MSME, innovators, academic and research fraternity


National Health Authority releases consultation paper on Drug Registry
News | March 31, 2022

National Health Authority releases consultation paper on Drug Registry

The Drug Registry intends to create a nationally recognized source of information on various systems of medicine in the country


Govt clears 49 applicants for PLI in Bulk Drugs
News | March 30, 2022

Govt clears 49 applicants for PLI in Bulk Drugs

The selected 49 applications are from 33 companies. Out of these 33 companies, 13 are Micro, Small and Medium Enterprises (MSMEs) besides some newly incorporated entities


OPPI summit calls for collaboration across stakeholders
News | March 30, 2022

OPPI summit calls for collaboration across stakeholders

The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India


GenScript wins Best CDMO award for the third time
News | March 30, 2022

GenScript wins Best CDMO award for the third time

The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".


Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes
Drug Approval | March 29, 2022

Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes

Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults


Dysval gets regulatory approval in Japan
Drug Approval | March 29, 2022

Dysval gets regulatory approval in Japan

Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients


Carestream Health India showcases two new products at IRIA
Medical Device | March 29, 2022

Carestream Health India showcases two new products at IRIA

As a partner with IRIA, the company had a significant booth presence on-ground during the conference.


University of Glasgow’s research centre to be named Mazumdar-Shaw Advanced Research Centre
News | March 29, 2022

University of Glasgow’s research centre to be named Mazumdar-Shaw Advanced Research Centre

John Shaw, who is a Glasgow University graduate, along with his wife Kiran Mazumdar-Shaw had gifted US $ 7.5 million to the university in July 2019


USFDA approves EUA for second booster dose of Moderna
News | March 29, 2022

USFDA approves EUA for second booster dose of Moderna

50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age